anti-SLC13A5 (SLC13A5) Antikörper

Bezeichnung:
anti-Solute Carrier Family 13 Member 5 Antikörper (SLC13A5)
Auf www.antikoerper-online.de finden Sie aktuell 21 Solute Carrier Family 13 Member 5 (SLC13A5) Antikörper von 8 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen SLC13A5 Proteine (3) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 25 SLC13A5 Produkte verfügbar.
Synonyme:
Indy, mINDY, NaC2/NaCT, Nact

Meistgesuchte Reaktivitäten zu anti-SLC13A5 (SLC13A5) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human SLC13A5 Antikörper:

anti-Mouse (Murine) SLC13A5 Antikörper:

anti-Rat (Rattus) SLC13A5 Antikörper:

Alle verfügbaren anti-SLC13A5 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Weitere Antikörper gegen SLC13A5 Interaktionspartner

Human Solute Carrier Family 13 Member 5 (SLC13A5) Interaktionspartner

  1. Data suggest that SLC13A5 plays a role in progression/cell proliferation of human hepatocellular carcinoma cells; here, RNA interference using shRNA against SLC13A5 decreased tumor burden in treatment of hepatocarcinoma in a xenograft tumor model in nude mice.

  2. Data suggest that SLC13A5 plays a role in progression/proliferation of human hepatocellular carcinoma cells; RNA interference using shRNA against SLC13A5 decreased tumor burden in treatment of hepatocarcinoma in a xenograft tumor model in nude mice. [REVIEW]

  3. Study identified additional SLC13A5 mutations in patients with chronic epilepsy starting in the neonatal period, with the mutations producing inactive Na+/citrate transporters.

  4. Studies show that SLC13A5 is a transporter in the plasma membrane that mediates the uptake of citrate into cells. It is expressed in hepatocytes, neurons, and spermatozoa. Its loss-of-function mutations are associated with neonatal epilepsy in humans. This is a single-gene disease with epilepsy resulting solely from the inactivity of SLC13A5. [review]

  5. In infants presenting with therapy resistant seizures in the first days after birth, without a clear history of hypoxic-ischemic encephalopathy, but with Punctate White Matter Lesions on their neonatal MRI (zeige C7ORF49 Antikörper), a diagnosis of SCL13A5 related epileptic encephalopathy should be considered.

  6. Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5).

  7. Eight patients from four families with SLC13A5 mutation are described. They have neonatal epilepsy, tooth hypoplasia, and developmental delay.

  8. SLC13A5 is a novel target gene of PXR (zeige NR1I2 Antikörper) and may contribute to drug-induced steatosis and metabolic disorders in humans.

  9. Screening of 68 additional unrelated individuals with early-onset epileptic encephalopathy for SLC13A5 mutations led to identification of one additional subject with heterozygous mutations of SLC13A5 and a similar clinical presentation as index subjects

  10. This paper describes the cloning and functional characterization of the human Na(+)-coupled citrate transporter (NaCT (zeige SLC13A2 Antikörper)).

Mouse (Murine) Solute Carrier Family 13 Member 5 (SLC13A5) Interaktionspartner

  1. The findings revealed the potentially important role of citrate and Slc13a5 in the development and function of teeth and bone.

  2. Our studies demonstrate a profound effect of mIndy on mammalian energy metabolism.

  3. Molecular cloning and transport properties of NaCT.

  4. Na+ -coupled di/tricarboxylate transport system expressed in neurons as NaC2/NaCT, which can transport the tricarboxylate citrate as well as dicarboxylates such as succinate, alpha-ketoglutarate, and malate.

SLC13A5 Antigen-Profil

Beschreibung des Gens

SLC13A5 is a tricarboxylate plasma transporter with a preference for citrate.

Alternative names and synonyms associated with SLC13A5

  • solute carrier family 13 (sodium-dependent citrate transporter), member 5 (SLC13A5) Antikörper
  • solute carrier family 13 member 5 (Tsp_08599) Antikörper
  • solute carrier family 13 (sodium-dependent citrate transporter), member 5 (Slc13a5) Antikörper
  • Indy Antikörper
  • mINDY Antikörper
  • NaC2/NaCT Antikörper
  • Nact Antikörper

Bezeichner auf Proteinebene für SLC13A5

solute carrier family 13 (sodium-dependent citrate transporter), member 5 , solute carrier family 13 member 5 , Na(+)/citrate cotransporter , sodium-coupled citrate transporter , sodium-dependent citrate transporter , solute carrier family 13, member 5 , novel solute carrier family 13 (sodium-dependent dicarboxylate transporter) (Slc13a2 or 3) member

GENE ID SPEZIES
417678 Gallus gallus
507000 Bos taurus
606984 Canis lupus familiaris
10907034 Trichinella spiralis
284111 Homo sapiens
237831 Mus musculus
266998 Rattus norvegicus
Ausgewählte Anbieter für anti-SLC13A5 (SLC13A5) Antikörper
Haben Sie etwas anderes gesucht?